Atossa Therapeutics
NasdaqCM:ATOS
$ 4,94
$-0,04 (-0,80%)
4,94 $
$-0,04 (-0,80%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-3,00
Earnings Per Share
$0,00
Revenue Per Share
0,00%
Gross Margin %
$0,04 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-3,00
Revenue Per Share
$0,00
Gross Margin %
0,00%
Market Cap
$0,04 B
Long-Term Debt
$0,00 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
EPS Earnings Per Share $-4,04 $-3,00 $-3,60 $-3,15 $-2,70 $-29,55 $-30,45 $-82,50 $-153,09 $-504,00 $-1.215,00 $-1.382,13 $-1.890,00 $-1.107,00 $-1.026,00
Earnings Earnings $-34,78M $-387,51M $-451,08M $-398,85M $-341,87M $-3,57B $-278,01M $-752,40M $-405,69M $-161,28M $-218,70M $-193,50M $-189,00M $-77,49M $-61,56M
RPS Revenue Per Share $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $30,67 $3,79 $6,30 $6,86 $0,00
Revenue Revenue $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $5,52M $0,53M $0,63M $0,48M $0,00M
OCF Operating Cash Flow $-29,76M $-21,03M $-20,94M $-20,76M $-16,47M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $-8,83M $0,00M $0,00M
FCF Free Cash Flow $-34,00M $-21,05M $-20,96M $0,00M $0,00M $0,00M $0,00M $0,00M $-6,59M $0,00M $0,00M $0,00M $-9,07M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 100,00% 21,67% 86,38% 0,00%
FCFS Free Cash Flow Per Share $-3,46 $-2,51 $-2,49 $-2,46 $-2,11 $-15,36 $-16,13 $-32,73 $-101,47 $-328,80 $-1.337,64 $-80,26 $-108,34 $-58,32 $-71,65
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 8,61M 129,17M 125,3M 126,62M 126,62M 120,82M 9,13M 9,12M 2,65M 0,32M 0,18M 0,14M 0,1M 0,07M 0,06M
×